Globe Newswire
Company Announcement
Copenhagen, 3 June 2024 No. 25/2024
Transactions in connection with share buyback programmeISS A/S, a leading workplace experience and facility management company, announced on 22 February 2024 a new share buyback programme, see company announcement no. 4/2024. The share buyback programme is executed in accordance Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 (the “Market Abuse... (continue reading...)
Press ReleaseNokia selected by Telehouse America to upgrade NYIIX peering exchange infrastructure in the US
- Upgrade to Telehouse’s NYIIX Peering Exchange, one of world’s largest neutral Internet Exchange Points (IXPs).
- NYIIX served from New York, New Jersey and Philadelphia locations will benefit from new, massively scalable, and future proof network platform.
- Nokia to deploy IP and optical interconnection solutions allowing Telehouse to launch 10, 100... (continue reading...)
LONDON, June 03, 2024 (GLOBE NEWSWIRE) -- TMF Group, a leading provider of compliance and administrative services, today launches the 11th edition of the Global Business Complexity Index (GBCI).
The comprehensive report analyses 79 jurisdictions which account for 93% of the world’s total GDP and 88% of net global FDI inflow. It compares 292 annually tracked indicators, offering data on key aspects of doing business across the globe.
This year’s study reveals... (continue reading...)
Kenmare Resources plc (“Kenmare” or “the Company” or "the Group")
3 June 2024
Fatality at the Moma Mine
Kenmare Resources plc (LSE:KMR, ISE:KMR) regrets to report a fatality at its Moma Titanium Minerals Mine (the "Mine" or "Moma") in northern Mozambique on 1 June 2024. Initial investigations found that the deceased, who was an excavator operator employed by one of Kenmare’s contractors, was involved in a fatal incident during the night... (continue reading...)
Hermed offentliggøres investorinformation for afdelingerne i Kapitalforeningen BLS Invest.
Investorinformationen offentliggøres som følge af Kapitalforeningen BLS Invests skifte af administrationsselskab fra Nykredit Portefølje Administration A/S til Investeringsforvaltningsselskabet SEBinvest A/S med virkning pr. dags dato.
Investorinformationen er blevet opdateret med konsekvensændringer og mindre redaktionelle ændringer som følge af skiftet til nyt... (continue reading...)
More Globe Newswire
View Older Stories-
Havila Shipping ASA: Extension of contract with Reach Subsea for the IMR vessel Havila Subsea
-
Offentliggørelse af investorinformationer, Kapitalforeningen Wealth Invest
-
Offentliggørelse af prospekt, Investeringsforeningen SEBinvest
-
Offentliggørelse af prospekter, Investeringsforeningen Wealth Invest
-
TPAY releases a white paper on How Open Banking Empowers Financial Freedom
-
Total voting rights
-
Dividend payment ex-date of Arco Vara AS
-
AUGA Tech, UAB is enlisting external financial and industry partners to bring its portfolio of "Mission no cost to nature" technologies to market
-
Preliminary data on early redemptions (prepayments)
-
Orion is developing the Finnish life science industry in a unique collaboration project
-
RAMSAY SANTE : Agreement reached with the government on funding of private hospitals
-
Flash News: OKX Announces Adjustments to Minimum Order Quantities for Select Futures Listings
-
FTI Consulting Adds Senior Chemicals Industry Expert to Further Expand Business Transformation Practice in Europe
-
Caledonia to file preliminary economic assessment on chosen approach to develop the Bilboes sulphide gold project
-
QIAGEN expands QIAstat-Dx syndromic testing menu in the U.S. with launch of molecular test to improve gastrointestinal care
-
Scatec ASA: Employee Share Purchase Programme 2024
-
Notification on the transaction concluded by manager in issuer's securities
-
Statkraft AS – Contemplating dual-currency green bond issuance
-
Pharming Group to participate in June investor conferences
-
Transaction in Own Shares
-
Voting Rights and Capital
-
Euronext completes the acquisition of Global Rate Set Systems
-
Transaction in Own Shares and Total Voting Rights
-
Total Voting Rights and Capital
-
Flash News: OKX Announces Enhancements to Portfolio Margin Mode to Optimize Trading Experience
-
BW Energy: Fixed Income Investor Meetings
-
Vallourec: Andre Lacerda Appointed Senior Vice President of South America (Tubes Activities)
-
BGHL (GBP): NAV(s)
-
BGHL (EUR): NAV(s)
-
Transgene - First Patient Enrolled in Phase II Part of Randomized Phase I/II Trial Evaluating Lead Cancer Vaccine TG4050 in Head and Neck Cancer
-
Number of voting rights as of May 31, 2024
-
BW Energy: Appraisal confirms material Hibiscus field reserve increase
-
Market Update
-
Start of Day Message
-
Ontex finalizes the divestment of its business in Pakistan
-
Ipsen initiates a share buy-back program to cover its free employee share-allocation plan
-
ALK presents positive phase 3 paediatric trial data offering new hope for children with respiratory allergies
-
Corbion reports the progress of its € 20 million share buyback program 27 May – 31 May 2024
-
New data with daridorexant to be presented at SLEEP 2024
-
Flash News: OKX to Support Mina Protocol's Upgrade
-
Flash News: OKX to Support Mina Protocol's Upgrade
-
Burning Rock Regains Compliance with NASDAQ Minimum Bid Price Requirement
-
NetAlly Unveils Next Generation LinkRunner® AT Network and Cable Testers
-
BIOPHTA raises 6.5 million Euros Seed Funding to transition its New Standard of Care for Eye Diseases to the Clinical stage
-
IXOPAY Appoints Brady Harris as CEO to Drive Global Payments Growth
-
AMD Unveils Next-Gen “Zen 5” Ryzen Processors to Power Advanced AI Experiences
-
AMD Accelerates Pace of Data Center AI Innovation and Leadership with Expanded AMD Instinct GPU Roadmap
-
AMD Extends AI and High-Performance Leadership in Data Center and PCs with New AMD Instinct, Ryzen and EPYC Processors at Computex 2024
-
Flash News: OKX Launches 100% Fee Rebate Campaign
-
Immutep Announces Clinical Collaboration with MSD to Evaluate Efti in Combination with KEYTRUDA® (pembrolizumab) in Pivotal Phase III Trial